�山ǿ�� News - Ted Fon

MNI scientist receives $1.5M grant for Parkinson's/ALS research

webfull — Thu, 02 Feb 2017 17:09:25 +0000

CQDM and Brain Canada join forces again in the funding of two new research projects to address unmet needs in brain research

CQDM and Brain Canada are proud to announce the funding of two new multi-disciplinary and multi-institutional research projects under the second edition of their Focus on Brain strategic initiative. The partners will award a total of $3M to two research teams to develop cutting-edge tools, technologies and platforms designed to accelerate the discovery of new drugs for brain and nervous system disorders.

Published: 2 February 2017

Quality control of mitochondria as a defense against disease

webfull — Tue, 21 Jan 2014 16:27:27 +0000

Scientists from the Montreal Neurological Institute and Hospital in Canada have discovered that two genes linked to hereditary Parkinson’s disease are involved in the early-stage quality control of mitochondria. The protective mechanism, which is reported in The EMBO Journal, removes damaged proteins that arise from oxidative stress from mitochondria.

Published: 21 January 2014

Unleashing the watchdog protein

webfull — Thu, 09 May 2013 18:38:16 +0000

Research opens door to new drug therapies for Parkinson’s disease

Published: 9 May 2013

Clinician-scientists at The Neuro receive funding for Parkinson’s and HIV research

webfull — Tue, 05 Feb 2013 21:44:34 +0000

November 27, 2012 - Clinician-scientists take a unique, integrated approach that is essential to advancing science and medicine. Problems encountered in the clinic inspire research and new findings from the labs are directly applied to patients’ needs. The integrated model is a hallmark of the Montreal Neurological Institute and Hospital – The Neuro, at �山ǿ�� and the MUHC and is now being replicated worldwide. Two clinician-scientists at The Neuro have been awarded grants today to further research on Parkinson’s disease and HIV/AIDS.

Published: 5 February 2013